Abstract
Long lasting insecticide treated mosquito nets (LLINs) provide both direct and indirect protection against bites from mosquitoes potentially transmitting malaria. Direct personal protection is provided to net users given both the net’s physical barrier and its insecticidal action. Indirect mass protection for the community is afforded through reduced infectious bites per person annually (entomological inoculation rate, EIR). Quantifying these protective effects can help strategize options for net interventions, particularly as insecticide-resistant mosquitoes spread.
These types of protection are inherently linked, rendering it impossible to empirically quantify the contribution of each to the overall ‘community effect’, instead we investigate this with a modelling framework and compare model predictions to trends with Demographic Health Survey (DHS) data.
Our modelling exercise predicts that in a situation with an EIR of 100, the reduction in EIR from an untreated net used by 80% of the population is 52% [95% CI: 12% - 84%] for users and 21% [95% CI: 0% - 57%] for non-users. Due to the impact of the insecticide, the reduction in EIR for LLINs is 89% [95% CI: 67% - 98%] for users and 74% [95% CI: 48% - 92%] for non-users, but this protection reduces as insecticide resistance in mosquitoes increases. Modelled trends in the difference in protection between users and non-users across endemicity and net usage levels are consistent with DHS data (2000-2018).
This study supports the concept of a community effect from LLINs, highlights the value of blocking and killing mosquitoes for community protection. Achieving high LLIN usage is always preferential, but there remains protection to non-users as the number of people using nets increases.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by Bill and Melinda Gates Foundation and IVCC.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This paper uses demographic health survey data that can be accessed at https://dhsprogram.com.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The deterministic malaria model used for this analysis can be found on GitHub (https://github.com/mrc-ide/dide-deterministic-malaria-model). The Demographic Health Survey data is publicly available at https://dhsprogram.com.
